We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) was one ...

The New Year's Champagne turned flat for Madrigal Pharmaceuticals (NASDAQ: MDGL) on Tuesday. Investors traded out of the ...

For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...

Pharma stocks are back in focus as obesity drugs, HIV prevention and biotech deal activity shape the outlook heading into ...

India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $496.45, a high estimate of $564.00, and a low estimate of $414.00. Witnessing a positive shift, the ...

Eli Lilly is a safer way to capitalize on AI-driven drug discovery.

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

While the drop in Ultragenyx stock certainly provides a lower entry point for new investors, the more prudent choice right ...

As of Friday, January 02, Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 60.00%, which has investors ...